PIII vs. AIRS, SERA, LFMD, BDSX, QIPT, CORBF, EUDA, BNR, XGN, and ENZ
Should you be buying P3 Health Partners stock or one of its competitors? The main competitors of P3 Health Partners include AirSculpt Technologies (AIRS), Sera Prognostics (SERA), LifeMD (LFMD), Biodesix (BDSX), Quipt Home Medical (QIPT), Global Cord Blood (CORBF), EUDA Health (EUDA), Burning Rock Biotech (BNR), Exagen (XGN), and Enzo Biochem (ENZ). These companies are all part of the "healthcare" industry.
P3 Health Partners vs.
AirSculpt Technologies (NASDAQ:AIRS) and P3 Health Partners (NASDAQ:PIII) are both small-cap business services companies, but which is the better investment? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, risk, dividends, valuation, media sentiment, earnings and community ranking.
AirSculpt Technologies has a beta of 1.71, suggesting that its share price is 71% more volatile than the S&P 500. Comparatively, P3 Health Partners has a beta of 1, suggesting that its share price has a similar volatility profile to the S&P 500.
AirSculpt Technologies has a net margin of -4.13% compared to P3 Health Partners' net margin of -6.95%. AirSculpt Technologies' return on equity of 2.22% beat P3 Health Partners' return on equity.
AirSculpt Technologies currently has a consensus target price of $5.00, suggesting a potential downside of 6.19%. P3 Health Partners has a consensus target price of $2.38, suggesting a potential upside of 1,052.91%. Given P3 Health Partners' stronger consensus rating and higher probable upside, analysts plainly believe P3 Health Partners is more favorable than AirSculpt Technologies.
91.5% of AirSculpt Technologies shares are owned by institutional investors. Comparatively, 7.8% of P3 Health Partners shares are owned by institutional investors. 78.3% of AirSculpt Technologies shares are owned by company insiders. Comparatively, 17.9% of P3 Health Partners shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
In the previous week, AirSculpt Technologies had 10 more articles in the media than P3 Health Partners. MarketBeat recorded 10 mentions for AirSculpt Technologies and 0 mentions for P3 Health Partners. AirSculpt Technologies' average media sentiment score of -0.04 beat P3 Health Partners' score of -0.75 indicating that AirSculpt Technologies is being referred to more favorably in the media.
AirSculpt Technologies has higher earnings, but lower revenue than P3 Health Partners. AirSculpt Technologies is trading at a lower price-to-earnings ratio than P3 Health Partners, indicating that it is currently the more affordable of the two stocks.
AirSculpt Technologies received 7 more outperform votes than P3 Health Partners when rated by MarketBeat users. Likewise, 36.67% of users gave AirSculpt Technologies an outperform vote while only 26.67% of users gave P3 Health Partners an outperform vote.
Summary
AirSculpt Technologies beats P3 Health Partners on 13 of the 18 factors compared between the two stocks.
Get P3 Health Partners News Delivered to You Automatically
Sign up to receive the latest news and ratings for PIII and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
P3 Health Partners Competitors List
Related Companies and Tools
This page (NASDAQ:PIII) was last updated on 1/20/2025 by MarketBeat.com Staff
